Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Title(s)
Professor of Health Policy and Clinical Practice
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Dartmouth Cancer Center
Principal Investigator, SYNERGY, Dartmouth's Clinical and Translational Science Institute

Department(s)
Health Policy and Clinical Practice
Medicine
Community and Family Medicine

Education
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Programs
Dartmouth Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice

Contact Information

Geisel School of Medicine at Dartmouth
HB7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-646-5664
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-646-5237
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU


Professional Interests

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, electronic health record data, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis


Selected Publications

 

Use of Ecological Momentary Assessment to Measure Affect-Based Feeling States Among Rural Breast Cancer Survivors: A Feasibility Study Guided by the Integrated Screening Action Model.
St Angelo M, Stevens CJ, Beidler LB, Emond JA, Tosteson ANA, Gunn CM
Int J Behav Med. 2025 Oct 27; doi: 10.1007/s12529-025-10407-5. Epub 2025 Oct 27.
PMID: 41145781

Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making.
Gunn CM, Boyer N, Sheikh S, Lee JM, Woloshin S, Specht JM, Hubbard RA, Bowles EJA, Su YR, Tosteson ANA
Med Decis Making. 2025 Oct 21;:272989X251379888. doi: 10.1177/0272989X251379888. Epub 2025 Oct 21.
PMID: 41117001

ASO Visual Abstract: Rurality and Use of Metastasis-Directed Therapies in Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
Ladage VP, Ramkumar N, Wang Q, O'Malley AJ, Colla CH, Wong SL, Tosteson ANA, Brooks GA
Ann Surg Oncol. 2025 Oct 18; doi: 10.1245/s10434-025-18586-x. Epub 2025 Oct 18.
PMID: 41109876

Comparing Trends in Telemedicine Use and Geographic Disparities in Utilization Among Patients With Cancer in the United States.
Mackwood M, Wang Q, Tosteson TD, Brooks G, Smith RE, Tosteson ANA
JCO Oncol Pract. 2025 Oct 9;:OP2400751. doi: 10.1200/OP-24-00751. Epub 2025 Oct 9.
PMID: 41066715

Rurality and Use of Metastasis-Directed Therapies for Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
Ladage VP, Ramkumar N, Wang Q, O'Malley AJ, Colla CH, Wong SL, Tosteson ANA, Brooks GA
Ann Surg Oncol. 2025 Sep 29; doi: 10.1245/s10434-025-18412-4. Epub 2025 Sep 29.
PMID: 41023546

Comparing clinical decision support systems for improving follow-up of abnormal cervical cancer screening test results.
Atlas SJ, Burdick TE, Wright A, Zhao W, Hort S, Aman DG, Thillaiyapillai M, John Orav E, Wint AJ, Smith RE, Gallagher KL, Housman ML, Chang FY, Diamond CJ, Zhou L, Haas JS, Tosteson ANA
J Biomed Inform. 2025 Oct;170:104908. doi: 10.1016/j.jbi.2025.104908. Epub 2025 Sep 9.
PMID: 40935221

The Clinical Utility of Real-Time Patient-Reported Outcomes in Cell Therapy Recipients.
Meehan KR, Doherty JR, King JR, Caldon KL, Hayes CA, Hill JM, Lizcano RA, Holthoff MM, O'Donnell EA, Mills P, Zhao W, Holt KR, Nelson EC, Tosteson ANA, Van Citters AD
Transplant Cell Ther. 2025 Sep 3; pii: S2666-6367(25)01393-4. doi: 10.1016/j.jtct.2025.08.018. Epub 2025 Sep 3.
PMID: 40912472

Modeling the impact of social determinants on breast cancer screening: a data-driven approach.
Ma G, Scully MG, Luo J, Feng JH, Gunn CM, diFlorio-Alexander RM, Tosteson ANA, Kraft SA, Marrero WJ
Front Med (Lausanne). 2025;12:1644287. doi: 10.3389/fmed.2025.1644287. Epub 2025 Aug 20.
PMID: 40909461

Digital divides in telehealth accessibility for cancer care in the United States.
Liu L, Onega T, Moen EL, Tosteson ANA, Smith RE, Wang Q, Cowan L, Wang F
NPJ Digit Med. 2025 Aug 19;8(1):534. doi: 10.1038/s41746-025-01931-5. Epub 2025 Aug 19.
PMID: 40830581

A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy.
Wright HN, Tosteson TD, Hourdequin KC, Ripple GH, Fuld AD, Dragnev KH, Amin M, Muralikrishnan S, McGrath EB, Stannard MG, Schofield LL, Lord-Halvorson S, Tosteson ANA, Brooks GA
Support Care Cancer. 2025 Aug 8;33(9):769. doi: 10.1007/s00520-025-09784-0. Epub 2025 Aug 8.
PMID: 40779182

View more publications on PubMed